Reneo Pharmaceuticals Inc (RPHM)
1.66
+0.06
(+3.75%)
USD |
NASDAQ |
May 16, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reneo Pharmaceuticals Cash and Short Term Investments (Quarterly): 82.84M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 82.84M |
| December 31, 2023 | 102.96M |
| September 30, 2023 | 125.61M |
| June 30, 2023 | 142.68M |
| March 31, 2023 | 93.79M |
| December 31, 2022 | 101.17M |
| September 30, 2022 | 116.08M |
| Date | Value |
|---|---|
| June 30, 2022 | 126.85M |
| March 31, 2022 | 138.66M |
| December 31, 2021 | 147.67M |
| September 30, 2021 | 157.73M |
| June 30, 2021 | 167.33M |
| March 31, 2021 | 91.22M |
| December 31, 2020 | 53.61M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
53.61M
Minimum
Dec 2020
167.33M
Maximum
Jun 2021
117.73M
Average
120.85M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 302.84M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 18.26M |